Login / Signup

Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder.

Stanislas DemuthNicolas CollonguesBertrand AudoinXavier AyrignacBertrand BourreJonathan CironMikael CohenRomain DeschampsFrançoise Durand-DubiefElisabeth MaillartCaroline PapeixAurélie RuetHelene ZephirRomain MarignierJerome De Sezenull null
Published in: Neurology (2023)
This study provides Class IV evidence that de-escalation of rituximab increases the probability of disease reactivation.
Keyphrases
  • spectrum disorder
  • diffuse large b cell lymphoma
  • open label
  • hodgkin lymphoma
  • randomized controlled trial
  • clinical trial
  • study protocol